// App-Quantinova.ai

e15609 : Predictive value of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) for patients with advanced HBV-associated HCC.

Researchers

Presenter

  • Zhan-Hong Chen

Principal Investigators

  • Jin-Xiang Lin

  • Ying-fen Hong

  • Min Dong

  • Qu Lin

  • Xiang-yuan Wu

Medical Centers

  • Department of Medical Oncology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • Department of Medical Oncology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • Department of Medical Oncology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Neutrophil lymphocyte ratio

  • Platelet-lymphocyte ratio

  • Lymphocyte to monocyte ratio

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final